Clinical Trial Update: Outcomes Associated With Early or Delayed Maintenance Treatment Post-Chronic Obstructive Pulmonary Disease Exacerbation

View source ↗

Summary

GlaxoSmithKline-sponsored trial completed, evaluating whether starting maintenance therapy early after a COPD exacerbation improves outcomes compared with delay…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED